19
Views
58
CrossRef citations to date
0
Altmetric
Original Article

Psychiatric Morbidity, Illicit Drug Use and Adherence to Zidovudine (AZT) Among Injection Drug Users with HIV Disease

, , &
Pages 475-487 | Published online: 07 Jul 2009

References

  • Des Jarlais D. C., Friedman S. R., Sotheran J. L., et al. Continuity and change within an HIV epidemic: Injecting drug users in New York City, 1984 through 1992. JAMA 1994; 271(2)121–127
  • Firlik A. D., Schrieber K. AIDS prevention by needle exchange. N. Y. State J. Med 1992; 92(10)426–430
  • Sorensen J. L., London J., Morales E. S. Group counseling to prevent AIDS. Preventing AIDS in Drug Users and Their Sexual Partners, J. S. Sorensen, L. A. Wermuth, D. R. Gibson, K. Choi, J. R. Guydish, S. L. Batki. Guilford Press, New York 1991; 99–115
  • Sorensen J. L., Batki S. L., Wilkinson K. Methadone maintenance treatment for AIDS‐affected addicts. J. Substance Abuse Treatment 1989; 6: 87–94
  • Selwyn P. A., Feingold A. F., Iezza A., et al. Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Ann. Intern. Med 1989; 110: 761–763
  • Umbricht‐Schneiter A., Cinn D. H., Pabst K. M., Bigelow G. E. Providing medical care to methadone clinic patients: Referral vs. on site care. Am. J. Public Health 1994; 4(2)207–210
  • Batki S. L., Ferrando S. J., London J., et al. Psychiatric disorders, drug use and HIV disease in HIV‐infected intravenous drug users. Am. J. Addict, 5: 249–258
  • Fischl M. A., Richman D. D., Grieco M. H., et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS‐related complex. N. Engl. J. Med 1987; 317: 185–191
  • Fischl M. A., Richman D. D., Hansen N., et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I (HIV) infection: A double‐blind placebo‐controlled trial. Ann. Intern. Med 1990; 112: 727–737
  • Curtis R., Friedman S. R., Neaigus A., et al. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rept 1994; 109(3)329–327
  • Nolan C. M. Failure of therapy for tuberculosis in human immunodeficiency virus infection. Am. J. Med. Sci 1992; 304(3)168–173
  • Ball S., Sepkowitz K. Tuberculosis and its management in patients with HIV disease. AIDS Reader 1994; 4: 181–198
  • Sackett D. L. The magnitude of compliance and noncompliance. Compliance with Therapeutic Regimens, D. L. Sackett, R. B. Haynes. Johns Hopkins Univeristy Press, Baltimore 1976; 9–25
  • Berg J. S., Dischler J., Wagner D. J., et al. Medication compliance: A health care problem. Ann. Pharmacotherapy 1993; 27: S1–24, (suppl.)
  • Adams S. G., Howe T. T. Predicting medication compliance in a psychotic population. J. Nerv. Ment. Dis 1993; 181(9)558–560
  • Wolpe P. R., Gorton G., Serota R., Sanford B. Predicting compliance of dual diagnosis inpatients with aftercare treatment. Hosp. Commun. Psychiatry 1993; 44(1)45–49
  • Fischl M. A. Adherence in the safety and efficacy study of zidovudine in the treatment of subjects with mildly symptomatic HIV. Paper presented at the Conference of Adherence in AIDS Clinical Trials, San Francisco, CA, April, 1991
  • Samet J. H., Libman H., Steger K. A., et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross‐sectional study in a municipal hospital clinic. Am. J. Med 1992; 92: 495–502
  • Wall T. L., Sorensen J., London J., (1993) Adherence to zidovudine (AZT) in HIV‐infected injection drug users, Problems of Drug Dependence 1992. Proceedings of the 54th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. 1992, L. S. Harris, et al. U.S. Government Printing Office, Washington, D.C., 292, NIDA Research Monograph Series No. 132
  • Stein M. D., Piette J., Mor V., et al. Differences in access to zidovudine (AZT) among symptomatic HIV‐infected persons. J. Gen. Intern. Med 1991; 6: 35–40
  • Richman D. D., Fischl M. A., Grieco M. H., et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS‐related complex: A double‐blind, placebo‐controlled trial. N. Engl. J. Med 1987; 317(45)192–197
  • Good D. J., Reynolds D. J., De Miranda P. Simultaneous quantification of zidovudine and its glucuronide in serum high‐performance liquid chromated trial. N. Engl. J. Med 1987; 317(45)1
  • Collier A., Henry K., Japour A., van der Horst C. Switching and combining anti‐retroviral therapies. AIDS Clinical Care 1993; 5: 33–37
  • Centers for Disease Control. Update: Acquired immunodeficiency syndrome—United States 1981–1988. Morbid Mortal Weekly Rept 1987; 36: 1–48, (suppl.)
  • Nathan D. G. Hematologic diseases. Cecil Textbook of Medicine19th ed., J. B. Wyngaarden, L. H. Smith, C. J. Bennett. W. B. Saunders, Philadelphia 1992; 828
  • Wu A., Chanarin I., Levi A. J. Macrocytosis of chronic alcoholism. Lancet 1974; 1: 829–831
  • Khantzian E. J., Treece C. DSM III psychiatric diagnosis of narcotic addicts. Arch. Gen. Psychiatry 1985; 42: 1067–1071
  • Rounsaville B. J., Weissman M. M., Kleber H., et al. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch. Gen. Psychiatry 1982; 39: 161–166
  • Lipsitz J. D., Williams J. B., Rabkin J. G., et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am. J. Psychiatry 1994; 151: 1662–1668
  • Perry S., Jacobsberg L. B., Fishman B., et al. Psychiatric diagnosis before serological testing for the human immunodeficiency virus. Am. J. Psychiatry 1990; 147: 89–93
  • Williams J. B. W., Rabkin J. G., Remien R. H., et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. Arch. Gen. Psychiatry 1991; 48: 124–130
  • Rothenberger P. H., Bornstein R. A., Nasrallah H. A., et al. Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment. Compr. Psychiatry 1993; 34: 150–158
  • Pantaleo G., Graziosi C., Fauci A. The immunopathogenesis of human immuno‐deficiency virus infection. N. Engl. J. Med 1993; 328: 327–335
  • Selwyn P. A., Alcabes P., Hartel D., et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N. Engl. J. Med 1992; 327: 1697–1703
  • McArthur J. C. Neurological and neuropathological manifestations of HIV infection. Neuropsychology of HIV Infection, I. Grant, A. Martin. Oxford University Press, New York 1994; 56–107
  • Schmitt F. A., Dickson L. R., Brouwers P. Neuropsychological response to anti‐retroviral therapy in HIV infection. Neuropsychology of HIV Infection, I. Grant, A. Martin. Oxford University Press, New York 1994; 276–294
  • O'Dowd M. A., McKegney P. F. Manic syndrome associated with zidovudine (letter). JAMA 1988; 260: 3587–3588
  • Crowe S. M., McGrath M. S., Volberding P. Anti‐HIV therapy. AIDS Clin. Care 1990; 2: 17–20
  • Wall T. L., Sorensen J. L., Batki S. L., et al. Adherence to zidovudine (AZT) among HIV‐infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend 1995; 37: 261–269

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.